Cancers in the extra-hepatic bile duct and gallbladder have a substantial incidence in Japanese and Thai populations. 1, 2) A relationship between infection with the liver fluke, Opisthorchis viverrini, and bile duct cancer has been documented in Thailand. 1) However, this infection is not found in Japan; instead, exogenous N-nitroso compounds and endogenous nitrosation are suspected to play a role in carcinogenesis. 1) Previously, Fox et al. used Helicobacter-specific 16S rRNA primers to identify the presence of Helicobacter species in 13 out of 23 bile samples and 9 out of 23 gallbladder tissues from Chilean patients with chronic cholecystitis.
3) The organisms could not be cultured, but the sequencing of 8 polymerase chain reaction (PCR)-amplicons revealed the presence of 5 strains of Helicobacter bilis (H. bilis), 2 strains of "Flexispira rappini" and one of H. pullorum. 3) Enterohepatic Helicobacter species are bile-resistant 4) and in mice, H. bilis is gram-negative with a fusiform to slightly spiraled shape measuring 0.5 by 4-5 µm, with 3-14 sheathed flagella; it has been identified in the liver, bile and lower intestine. 5) H. bilis in bile causes chronic active hepatitis 3) and inflammatory bowel diseases in mice 6) and rats 7) and experimental infections with the organism have fulfilled Koch's postulates.
In this study, we analyzed whether H. bilis was present in human bile samples using PCR in bile samples from patients with biliary tract and gallbladder cancers, gallstone/cholecystitis patients and patients with non-biliary diseases, using H. bilis-specific PCR and sequencing. The study was approved by the institutional review boards of Nippon Medical School and permitted by Chiang Mai University. All bile samples were frozen at −70°C after collection, and the Thai samples were placed on dry ice and transferred to Tokyo by air. DNA extraction and amplification of H. bilis DNA by PCR DNA was extracted from the bile samples as follows. The bile samples (100 µl) were placed in 1.5-ml tubes and centrifuged at 8000 rpm for 10 min; the pellet was suspended in Tris/HCl (pH 8.0) and 10 mM ethylenediaminetetraacetic acid (EDTA) buffer (400 µl each), and then 45 µl of 10% sodium dodecyl sulfate (SDS; pH 7.2), 50 µg of proteinase K, and 20 µg of RNAse were added. The tubes were incubated at 37°C for more than 3 h. Next, 450 µl of phenol-Tris buffer was added, and the tubes were centrifuged at 14 000 rpm for 5 min to obtain the supernatant. Four hundred and fifty microliters of phenol-chloroform was added, the tubes were centrifuged, and 450 µl of chloroform was added to the supernatant, followed by centrifugation. Thirty-five microliters of a solution of sodium acetate (3 M, pH 5.2) and 850 µl of 100% ethanol were added to the supernatant, then 500 µl of 80% ethanol was added and the mixture was centrifuged at 14 000 rpm for 5 min. The resulting pellet was dried and diluted with TE buffer (10 mM Tris, 1 mM EDTA).
MATERIALS AND METHODS

Patients
A specific primer set with sequences that are identical to selected H. bilis 16S ribosomal RNA sequences (culture collection: ATCC51630, GenBank accession no.: U18766; ATCC51631, U18767; ATCC51632, U18768) was utilized. H. bilis-specific primer pairs HEBI-F1 and HEBI-R1 were used. The primers have the following sequences: HEBI-F1 5′-GGAAAGGGGCTTTCAATA-AAG-3′ (forward), HEBI-R1 5′-GGCTGATCCTTTAGC-GAAGG-3′ (reverse). Nested PCR was performed using the primer pairs, HEBI-F2 and HEBI-R2, which are located between HEBI-F1 and HEBI-R1. The primers have the following sequences: HEBI-F2 5′-GAATGAGAAATTGAT-GTTGTGAAG-3′ (forward), HEBI-R2 5′-TCTTTGGAC-GATAAATCGAT-3′ (reverse). All oligonucleotides were obtained by chemical synthesis using the PerSeptive 8900 (PE Biosystems, Foster City, CA). TaqMan probes, that had been modified with a fluorescent tag (purchased from Greiner Japan, Inc., Tokyo). Five microliters of the DNA preparation was added to a 50-µl reaction mixture containing 50 µM of each primer, 5 µl of 10× PCR buffer, 2.5 units of Taq polymerase in 0.2 µl of buffer, 200 µM each of the four deoxynucleotides, and 34.8 µl of ddH 2 O. The preparations were denatured at 94°C for 1 min, annealed at 55°C for 2 min, and elongated at 72°C for 3 min (1 cycle), then denatured at 94°C for 45 s, annealed at 55°C for 1 min, and elongated at 72°C for 1 min (39 cycles), and finally incubated at 72°C for 10 min. The amplified products were analyzed by electrophoresis on a 1.2% agarose gel and stained with ethidium bromide. H. bilis genomic DNA (ATCC51630), kindly provided by one of the co-authors (J. G. Fox), was used as a positive control. Sequencing of H. bilis DNA The 2nd PCR products of the H. bilis-specific DNA were purified using a "GFX" PCR DNA and Gel Band Purification Kit (Amersham Pharmacia Biotech, Piscataway, NJ). Direct sequencing was then performed using the specific primers and a Cycle Sequencing Core Kit (Perkin-Elmer, Chiba) with an automated DNA sequencer (ABI Prism TM377, Applied Biosystems, Foster City, CA). The sequencing procedure was performed at least twice on both the sense and anti-sense strands. Specificity of PCR for H. bilis A PCR assay using the first primers (HEBI-F1 and R1), and the second primers (HEBI-F2 and R2) and 2% agarose gel electrophoresis with a positive control of H. bilis genomic DNA (ATCC 51630) were applied to the genomic DNA of the following 18 organisms: 8) except for the DNA extraction. In this study, DNA was extracted using a "GeneReleaser" Kit (Bioventures, Inc., Murfreesboro, TN). After PCR amplification, the PCR amplicons were identified by agarose gel electrophoresis and Southern blot hybridization. Statistics Statistical analyses were performed using the χ 2 test and the two-tailed Fisher's exact test with Yates' correction. A probability value of <0.05 was considered significant. We calculated the unadjusted odds ratios using the SPSS software system for the PC (SPSS 7.5J for Windows, SPSS, Inc., Tokyo).
RESULTS
H. bilis sequence analysis PCR amplicons specific for H. bilis were identified using agarose gel electrophoresis and an H. bilis-positive control (ATCC51630). A DNA fragment of 99 base pairs was identified in the bile samples and the H. bilis-positive control using primer pairs HEBI-F2 and HEBI-R2 (Fig. 1) . Six H. bilis PCR-positive samples and an H. bilis-positive control were directly sequenced from the PCR-amplicons to verify the identity of H. bilis. All 6 amplicons and the positive control exhibited the identical H. bilis-specific sequence (CAA TTT-GTGCGGA GACTAGACTT AGTGTCTGTC GCACAA-GCAA ATTGCGAACT CATCGAT). Homology research comparing the identified sequence with the GenBank nucleic acid sequence database produced a high score of 149 bits for H. bilis U18766, U18767, AF054570, AF054571 and AF054572, followed by 141-101 bits for H. bilis U51873, U18768, AF252626 and other Helicobacter species (AF047851, AF072333, AJ011431, AF225546). Homology with all other known organisms was lower than 48 bits. Specificity of PCR for H. bilis Nested PCR assay using the first primers (HEB1-F1 and R-1), and the second primers (HEB1-F2 and R2) and gel electrophoresis produced negative results for the genomic DNA of the 18 organisms representing normal flora or pathogens of the human gastrointestinal tract. H. bilis DNA in bile by PCR Thirteen out of 15 (87%) of the Japanese patients and 11 out of 14 (79%) of Thai patients with bile duct or gallbladder cancer tested positive for H. bilis in their bile (Table I) 
DISCUSSION
Helicobacter species are known to colonize the gastrointestinal tract of humans and animals. 4) The presence of H. pylori in the stomach is considered the most important etiological factor in the formation of peptic ulcers and gastric malignancies in humans. 9) Two classes of Helicobacter species have been identified, i.e. gastric and enterohepatic Helicobacter spp. H. pylori belongs to the gastric class, and H. bilis is an enterohepatic Helicobacter sp. 4) H. bilis was originally identified in the diseased livers and intestines of aged inbred mice. 5) Recently, H. bilis has been isolated from the stomach of dogs and gerbils, the cecal contents of gerbils, and the feces of cats. 4) In animals, H. hepaticus, H. bilis and H. canis have been associated with biliary tract and hepatic inflammation, and H. hepaticus infection is known to induce multifocal necrotic hepatitis and markedly increased risk of hepatic carcinoma in A/JCr mice. 4, 10) In human, H. bilis was first identified in the bile and gallbladder tissue in Chilean patients with chronic cholecystitis. Fox and co-workers 3) identified the presence of H. bilis by PCR and sequencing of DNA from bile and gallbladder tissue of Chilean patients with cholecystitis; however, cultures of H. bilis were unsuccessful. Thus, the role of bile-resistant Helicobacter spp. in the pathogenesis of biliary tract cancer has become a topic of great interest to bacteriologists and gastroenterologists.
11) Here, we report the first PCR evidence of H. bilis in bile samples from humans with malignant diseases of the biliary tract and gallbladder.
The aim of this study was to determine the incidence of H. bilis DNA in bile samples of patients from countries with high incidences of hepatobiliary malignancy and to clarify the frequencies of H. bilis positivity in patients with malignant and benign biliary diseases or non-biliary diseases. Our results indicate that 38-50% of bile samples from patients with benign diseases and 79-87% of samples from patients with malignant diseases of the biliary tract and gallbladder were positive for H. bilis DNA in both Japanese and Thai patients. The odds ratios for bile duct or gallbladder cancer with H. bilis in comparison with gallstone and/or cholecystitis were 6.50 (95%CI 1.09-38.63) for Japanese and 5.86 (1.31-26.33) for Thai patients. Only 29% of patients with non-biliary diseases exhibited H. bilis positivity in Japanese, and the presence of H. bilis in the bile increased the risk of bile duct or gallbladder cancer.
Some authors have detected H. pylori in the bile using PCR and have suggested a possible association with cholecystitis.
12, 13) However, we tested the bile samples for H. pylori DNA and found only one bile sample (1.3%) that was H. pylori-positive. Since bile inhibits the growth of H. pylori in vitro 14) and H. pylori has difficulty surviving in bile in vivo, 15) our results seem reasonable. Our data suggest that H. pylori infection is not a risk factor for biliary malignancy. A previous study by Fox and colleagues 3) showed that 5/8 (63%) amplicons detected by PCR in human bile were identified by sequencing as H. bilis; two other strains were identified as 'Flexispira rappini,' and one strain was identified as H. pullorum. We did not examine for the presence of other Helicobacter species in this study because H. bilis is thought to be the most prevalent Helicobacter species in bile of multiple animal hosts, including human. 3, 4, 6, 7) One of the limitations of this study was the fact that H. bilis cultures were not obtained. Further study by bacteriologists is necessary to determine the optimal conditions for growing H. bilis in vitro. However, we believe that the positive H. bilis results in this study are reliable because (1) we used an authorized positive control for H. bilis genomic DNA that was extracted from H. bilis strain ATCC51630, (2) DNA direct sequencing was used to examine 6 amplicons and these amplicons showed the highest homology with H. bilis, and (3) 18 species of bacteria known to colonize the human gastrointestinal tract produced negative PCR results.
Rudi et al. 16) reported that Helicobacter species were not detected by PCR in bile from German patients with biliary diseases. Germany has a low incidence of bile duct and gallbladder cancer, so they assumed that the discrepancy between their results and those of Fox et al. 3) could be explained by regional differences in the distribution of bile-resistant Helicobacter species. There is a possibility that geographic regional differences in biliary malignancy between low-risk areas, like Germany, and high-risk areas, like Japan and Thailand, 2) may account for the absence and presence of H. bilis, respectively. Indeed, the first report identifying the presence of H. bilis in bile 3) was made in Chile, where the incidence and mortality rate of biliary tract malignancies are the highest in the world. As Fox and colleagues pointed out, 3) a difference of approximately 30 times between high-risk populations and lowrisk populations suggests the presence of strong environmental factors and/or host-environmental interactions in biliary tract carcinogenesis.
Blaser explained the findings of Helicobacter DNA in the biliary tract of patients with cholecystitis in terms of several possible hypotheses 11) ; (1) the finding may be artificial, but he considered this unlikely, (2) Helicobacter species may represent normal biota (flora) of the biliary tract of humans and have no obvious pathogenetic role, (3) Helicobacter species may represent normal bowel biota that secondarily colonize damaged tissue, (4) Helicobacter species may represent transient bowel organisms that secondarily colonize previously injured tissue in a manner analogous to the role of Salmonella typhi in the higher risk of biliary tract cancers in typhoid carriers, (5) the Helicobacter species may be normal inhabitants of the biliary tract but contribute to increased risk of disease, analogous to the increased risk of ulcer disease with H. pylori colonization of the stomach and (6) the Helicobacter species may be newly introduced high-grade pathogens that play a strong role in disease pathogenesis, analogous to the role of Mycobacterium tuberculosis in causing chronic inflammatory pulmonary disease. Combined infections of H. bilis and other bacteria known to colonize the human gastrointestinal tract are presumably possible in the biliary tract.
The mechanism of biliary tract carcinogenesis by H. bilis infection is unclear. 11) Experimentally, H. bilis induced typhlitis, colitis, 6, 7) and hepatitis 5) in mice. Biochemically, H. bilis is oxidase, urease and catalase-positive, reduces nitrate to nitrite and is resistant to nalidixic acid and cephalothin. 5) Chronic inflammation by H. bilis infection along with tissue injury from the bile may be at least partly responsible for human biliary tract carcinogenesis. A relation between Opisthorchis viverrini infection and cholangiocarcinoma has been reported in Thailand, 1) but not in Japan. Gallstones are also known to increase the risk of gallbladder cancer. No evidence of a causal relationship between H. bilis and biliary tract malignancy was presented in this study, but H. bilis may have a pathogenic role in biliary malignancy.
In conclusion, we found H. bilis at a significantly higher incidence in bile from biliary tract and gallbladder cancer patients than in patients with gallstones/cholecystitis or pancreatic diseases using H. bilis-specific PCR and sequencing. We postulate that H. bilis infection in the bile may affect the risk of cancer in the bile duct and gallbladder.
